Bioheart
Biotech company focused on the development of effective cell technologies to treat cardiovascular diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€11—16m (Dealroom.co estimates Oct 2014.)
Sunrise Florida (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Early VC | ||
N/A | $15.0m | Early VC | |
N/A | N/A | IPO | |
$1.0m | Seed | ||
N/A | $230k | Seed | |
N/A | $100k | Seed | |
N/A | $150k | Seed | |
N/A | $470k | Seed | |
$3.0m | Early VC | ||
Total Funding | €18.1m |